BPC-157
10 mg
Synthetic gastric-protein-related peptide investigated for tissue protection and repair in preclinical models.
Research use only. Not for human or veterinary use.
Bundle & save
Buy more, save more - discounts apply automatically.
Related compounds
Frequently researched together
Batch documentation
Quality, documented
BPC-157
Looking for a batch report?
A certificate for BPC-157 is not currently published. Contact our team with the product name and batch number so we can help you find the relevant documentation.
Request documentationTechnical specifications
Compound information
Molecular profile
About BPC-157
- Type
- Synthetic 15-residue peptide
- CAS number
- 137525-51-0
- Molecular weight
- 1419.5 g/mol
- Amino acids
- 15
- Fatty acid chain
- Not specified in the source
Storage requirements
Stability information
- Sealed vial · lyophilized
- −20 °C for powder storage. Follow the instructions supplied with your batch.
- Reconstituted temperature
- 2–8 °C. Follow the handling requirements for your formulation.
- Shelf life analysis
- No batch-specific stability analysis is published here. Refer to the label or batch documentation for expiry dating.
Reference storage conditions are not a shelf-life guarantee. Batch-specific instructions take precedence.
Literature & compound records
The research behind BPC-157
Explore 7 research references and compound records. Expand a reference for its full citation and source.
01
Peer-reviewed literature
The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration
Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. Journal of applied physiology (Bethesda, Md. : 1985). 2011;110(3):774-780. doi:10.1152/japplphysiol.00945.2010.
Read source02
Scientific reports · 2020
Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway
Hsieh MJ, Lee CH, Chueh HY, Chang GJ, Huang HY, Lin Y, Pang JS. Scientific reports. 2020;10(1):17078. doi:10.1038/s41598-020-74022-y.
Read source03
Current neuropharmacology · 2016
Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications
Sikiric P, Seiwerth S, Rucman R, Kolenc D, Vuletic LB, Drmic D, Grgic T, Strbe S, Zukanovic G, Crvenkovic D, Madzarac G, Rukavina I, Sucic M, Baric M, Starcevic N, Krstonijevic Z, Bencic ML, Filipcic I, Rokotov DS, Vlainic J. Current neuropharmacology. 2016;14(8):857-865. doi:10.2174/1570159x13666160502153022.
Read source04
Gut and liver · 2020
Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye's Stress Coping Response: Progress, Achievements, and the Future
Sikiric P, Hahm KB, Blagaic AB, Tvrdeic A, Pavlov KH, Petrovic A, Kokot A, Gojkovic S, Krezic I, Drmic D, Rucman R, Seiwerth S. Gut and liver. 2020;14(2):153-167. doi:10.5009/gnl18490.
Read source05
Neural regeneration research · 2022
Pentadecapeptide BPC 157 and the central nervous system
Vukojevic J, Milavić M, Perović D, Ilić S, Čilić AZ, Đuran N, Štrbe S, Zoričić Z, Filipčić I, Brečić P, Seiverth S, Sikirić P. Neural regeneration research. 2022;17(3):482-487. doi:10.4103/1673-5374.320969.
Read source06
Bone · 1999
Osteogenic effect of a gastric pentadecapeptide, BPC-157, on the healing of segmental bone defect in rabbits: a comparison with bone marrow and autologous cortical bone implantation
Sebecić B, Nikolić V, Sikirić P, Seiwerth S, Sosa T, Patrlj L, Grabarević Z, Rucman R, Petek M, Konjevoda P, Jadrijević S, Perović D, Slaj M. Bone. 1999;24(3):195-202. doi:10.1016/s8756-3282(98)00180-x.
Read source07
Molecules (Basel, Switzerland) · 2014
Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts
Chang CH, Tsai WC, Hsu YH, Pang JH. Molecules (Basel, Switzerland). 2014;19(11):19066-19077. doi:10.3390/molecules191119066.
Read source
These references describe research materials, not testing of Pepvoro batches.
